Orchestra BioMed Holdings, Inc. OBIO
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.75M | -23.76M | -20.69M | 6.25M | -20.83M |
| Total Depreciation and Amortization | 101.00K | 96.00K | 90.00K | 82.00K | 81.00K |
| Total Amortization of Deferred Charges | 65.00K | 65.00K | 64.00K | 64.00K | 59.00K |
| Total Other Non-Cash Items | -1.59M | 4.15M | 2.03M | 3.62M | 3.60M |
| Change in Net Operating Assets | 635.00K | 111.00K | -3.66M | -12.28M | 2.54M |
| Cash from Operations | -19.54M | -19.33M | -22.17M | -2.27M | -14.55M |
| Capital Expenditure | -398.00K | -254.00K | -184.00K | -33.00K | -310.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.36M | -23.06M | 10.50M | -17.68M | -38.27M |
| Cash from Investing | 20.97M | -23.31M | 10.32M | -17.71M | -38.58M |
| Total Debt Issued | 0.00 | 35.00M | -- | 0.00 | 20.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.02M | 8.00K | 5.88M | 1.54M | 57.78M |
| Repurchase of Common Stock | -162.00K | -262.00K | -354.00K | -468.00K | -269.00K |
| Issuance of Preferred Stock | -- | -- | -- | 12.56M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -972.00K | -1.11M |
| Cash from Financing | 5.86M | 34.75M | 5.53M | 12.66M | 76.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.29M | -7.90M | -6.32M | -7.32M | 23.26M |